CALL US ON
+91 2553 691200
Business Hours: 9.00 am to 5.00 pm
- Products
- Supply Chain Solutions
- Custom Synthesis
- Facilities
- About us
- Investor
- Annual Reports
- Annual Returns
- Disclosures under Regulation 46 of SEBI (LODR) Regulations
- Code of Conduct insider Trading
- Whistle Blower Policy
- Code of fair disclosure
- Corporate Governance
- Corporate Information
- Prospectus
- Grievance Cell
- Shareholding Pattern
- Vigil Machanism
- AGM & Compliances
- Quarterly/Half Yearly Results
- Notices
- Policies
- Encumbrance by Promotors
- Regulation 30
- CSR
-
Product Finder
- OR
Quetiapine Fumarate IP/BP/USP
Uses:
Treatment of Schizophrenia,bipolar disorder,moderate to severe manic episodes in bipolar disorder,major depressive episodes in bipolar disorder,
Identifiers
- CAS No:
- [111974-72-2]
- BRN No:
- -
- UN No:
- -
Properties
- Molecular Formula:
- C25H29N3O6S
- Molecular Weight:
- 499.582 [g/mol]
Hazards
-->
Specifications
| Sr. No. | Test | Limits |
|---|---|---|
| 1 | Description | A white to off white powder |
| 2 | Identification Test | HPLC, IR |
| 3 | Loss on Drying at 105°C (% w/w) | NMT 0.5 % |
| 4 | Heavy Metal | NMT 20 PPM |
| 5 | Sulphated Ash (% w/w) | NMT 0.1 % |
| 6 | Fumaric acid Content (%) | 12.6 – 13.6 % |
| 7 | Assay by HPLC (%)On dried basis | 98.00 % – 102.00 % |
Get Quote Now
Request a Free Quote Today
Order Samples
Order Samples for R & D
USV Ltd.
Feb 2010
“ The focus on regularity of QA compliance makes VSCL an extremely competitive player in the Intermediates and API space.”
Feb 2010
